StockData
Mustang Bio, Inc. logo

Mustang Bio, Inc. (MBIO) stock

MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.38−0.01 (-2.56%)

Close on Nov 18, 2026Market cap $2.88MP/E –Yield –

Mustang Bio operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Mustang Bio's operating income for the twelve months ending Jun 30, 2026 was -$3.52M. For fiscal 2025 it was -$2.43M. The highest annual figure on record is -$2.43M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.43M–
FY2024Dec 31, 2024-$16.25M–
FY2023Dec 31, 2023-$49.26M–
FY2022Dec 31, 2022-$76.16M–
FY2021Dec 31, 2021-$66.72M–
FY2020Dec 31, 2020-$56.81M–
FY2019Dec 31, 2019-$45.89M–
FY2018Dec 31, 2018-$31.22M–
FY2017Dec 31, 2017-$31.79M–
FY2016Dec 31, 2016-$11.36M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.17M–
Q1 FY2026Mar 31, 2026-$1.06M–
Q4 FY2025Dec 31, 2025-$670.00K–
Q3 FY2025Sep 30, 2025-$624.00K–
Q2 FY2025Jun 30, 2025-$885.00K–
Q1 FY2025Mar 31, 2025-$253.00K–
Q4 FY2024Dec 31, 2024-$1.02M–
Q3 FY2024Sep 30, 2024-$1.46M–
Q2 FY2024Jun 30, 2024-$8.54M–
Q1 FY2024Mar 31, 2024-$5.23M–
Q4 FY2023Dec 31, 2023-$8.74M–
Q3 FY2023Sep 30, 2023-$10.31M–
Q2 FY2023Jun 30, 2023-$13.89M–
Q1 FY2023Mar 31, 2023-$16.32M–
Q4 FY2022Dec 31, 2022-$19.43M–
Q3 FY2022Sep 30, 2022-$18.85M–
Q2 FY2022Jun 30, 2022-$18.24M–
Q1 FY2022Mar 31, 2022-$19.64M–
Q4 FY2021Dec 31, 2021-$20.12M–
Q3 FY2021Sep 30, 2021-$17.08M–
Q2 FY2021Jun 30, 2021-$14.44M–
Q1 FY2021Mar 31, 2021-$15.09M–
Q4 FY2020Dec 31, 2020-$20.74M–
Q3 FY2020Sep 30, 2020-$10.43M–
Q2 FY2020Jun 30, 2020-$14.12M–
Q1 FY2020Mar 31, 2020-$11.52M–
Q4 FY2019Dec 31, 2019-$15.92M–
Q3 FY2019Sep 30, 2019-$10.00M–
Q2 FY2019Jun 30, 2019-$10.21M–
Q1 FY2019Mar 31, 2019-$9.75M–
Q4 FY2018Dec 31, 2018-$11.85M–
Q3 FY2018Sep 30, 2018-$7.66M–
Q2 FY2018Jun 30, 2018-$5.24M–
Q1 FY2018Mar 31, 2018-$6.48M–
Q4 FY2017Dec 31, 2017-$15.73M–
Q3 FY2017Sep 30, 2017-$7.08M–
Q2 FY2017Jun 30, 2017-$5.67M–
Q1 FY2017Mar 31, 2017-$3.31M–
Q4 FY2016Dec 31, 2016-$7.83M–
Q3 FY2016Sep 30, 2016-$1.67M–

More Mustang Bio figures

See a number that looks wrong?